Diagnostic, Predictive and Prognostic Biomarkers for Neurodegenerative Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 403
Special Issue Editor
Interests: neurodegenerative disorders; Epilepsy; Parkinson’s disease; Alzheimer’s disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases are increasingly prevalent pathologies that are unfortunately occurring at younger and younger ages. Although many of these pathologies do not yet have a well-defined substrate, their evolution can be assessed through serological biomarkers and imaging procedures. Moreover, the effectiveness of treatment can be assessed through paraclinical analyses. There is still a need to develop more targeted therapeutic strategies for neurodegenerative diseases, including early detection in the presymptomatic phase with the help of serological biomarkers that are easy to quantify and reproduce. Moreover, imaging studies corroborated by serological investigations in dynamics can be correlated with the evolution of the disease, allowing the assessment of the effectiveness of treatment. Therefore, we invite you to share your experience regarding these pathologies in order to establish new therapeutic approaches and facilitate the early discovery of neurodegenerative diseases.
Dr. Ionica Pirici
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- biomarkers
- medical imaging
- pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
